NUVATION BIO INC.
Ownership & governance
Executives 5Directors 7Avg age 62Avg tenure 4.8y
DH
David Hung
Chief Executive Officer
Age 68Since 2018-03-19Profile →
+11
Executives5
DH
David Hung→
Chief Executive Officer
Age 68Since 2018-03-19
PS
Philippe Sauvage→
Director of Finance/CFO
Age 49Since 2024-10-06
DL
Dong Fang Liu→
Chief Tech/Sci/R&D Officer
Age 56Since 2022-07-17
DH
David Hanley→
Chief Tech/Sci/R&D Officer
Age 56Since 2021-05-31
GH
Gary Hattersley→
Chief Tech/Sci/R&D Officer
Age 59Since 2019-05-31
Board of directors7
DH
David Hung→
Chairman
Age 68Since 2024-09-02
RB
Robert Bazemore→
Director/Board Member
Age 58Since 2020-06-30
KB
Kim Blickenstaff→
Director/Board Member
Age 73Since 2019-07-31
KF
Kathryn Falberg→
Director/Board Member
Age 65Since 2020-09-30
TV
Tony Vernon→
Director/Board Member
Age 70Since 2019-05-31
RM
Robert Mashal→
Director/Board Member
Age 67Since 2024-01-07
XC
Xiang Ming Cui→
Director/Board Member
Age 57Since 2024-04-08
Shareholders5
| Name | Stake | Shares |
|---|---|---|
| David Hung | 17.02 % | 59,281,054 |
| Fidelity Management & Research Co. LLC | 14.93 % | 51,989,593 |
| Decheng Capital LLC | 7.454 % | 25,954,439 |
| BlackRock Advisors LLC | 6.626 % | 23,072,683 |
| Vanguard Capital Management LLC | 3.339 % | 11,626,198 |
Catalog · 2026-07-09
Registry officers12
| Name | Role | Since | Shares |
|---|---|---|---|
| David Hanley | Chief Tech/Sci/R&D Officer | 2021-05-31 | - |
| David Hung | Chairman | 2024-09-02 | - |
| David Hung | Chief Executive Officer | 2018-03-19 | - |
| Dong Fang Liu | Chief Tech/Sci/R&D Officer | 2022-07-17 | - |
| Gary Hattersley | Chief Tech/Sci/R&D Officer | 2019-05-31 | - |
| Philippe Sauvage | Director of Finance/CFO | 2024-10-06 | - |
| Kathryn Falberg | Director/Board Member | 2020-09-30 | - |
| Kim Blickenstaff | Director/Board Member | 2019-07-31 | - |
Registry · as of 2026-07-09
Institutional (13F)
Loading Form 13F holders…
Fund membership
Loading fund baskets…
Street consensus
Consensus strong buyMean target 13Range 7–21Analysts 11
7Mean 1321
- Strong buy 3
- Buy 9
- Hold 1
Broker actions40 of 81
| Firm | Action | To | Target | Date |
|---|---|---|---|---|
| Citigroup | Initiated | Buy | 12 | 2026-09-30 |
| Citizens | Reiterated | Market Outperform | 10 | 2026-09-16 |
| Wedbush | Reiterated | Outperform | 11 | 2026-09-16 |
| Cantor Fitzgerald | Initiated | Overweight | — | 2026-08-21 |
| JP Morgan | Initiated | Overweight | 13 | 2026-08-18 |
| RBC Capital | Maintained | Outperform | 20 | 2026-08-07 |
| HC Wainwright & Co. | Maintained | Buy | 21 | 2026-07-27 |
| Wedbush | Reiterated | Outperform | 11 | 2026-07-23 |
| RBC Capital | Maintained | Outperform | 19 | 2026-07-07 |
| Truist Securities | Maintained | Buy | 13 | 2026-07-07 |
| RBC Capital | Reiterated | Outperform | 20 | 2026-05-05 |
| Wedbush | Reiterated | Outperform | 11 | 2026-05-05 |
Firm rows and rating mix from Yahoo Finance; mean target is Yahoo’s aggregate until OpenFilings derives consensus from broker rows.